abstract |
A soluble monomeric HLA-I/peptide molecule wherein a peptide ligand is bound to soluble monomeric HLA-I and wherein the peptide is a cancer or virus antigenic peptide, particularly for use in a method of therapeutic treatment of the human or animal body, more particularly cancer, and pharmaceutical compositions. |